Join us to explore Australia’s fast and pragmatic regulatory environment, internationally recognised quality systems, and tax incentives as strategic advantages for your upcoming clinical trial. Exclusively for senior biotech leaders, places are strictly limited.
In association with:



Attendance: Free to attend, pre-registration essential by submitting your registration here.
Contact
Expert Guide to The Australian Advantage: Accelerating Early Phase Clinical Trials
Thursday 19 March 2026, 12.00-14.00
19 March 2026 12:00
High Commission of Australia in London
Strand
WC2B 4LA
United Kingdom
Strand
WC2B 4LA
United Kingdom